SMTL ID : 3s43.1

HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug amprenavir

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.26 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 478: {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER(Non-covalent)

478.1: 21 residues within 4Å: Chain A: D.25, G.27, A.28, D.30, G.48, G.49, I.50, I.82, I.84 Chain B: L.23, D.25, G.27, A.28, D.29, D.30, I.32, V.47, G.48, G.49, I.50, I.84 19 PLIP interactions: 8 interactions with chain B, 11 interactions with chain A Hydrophobic interactions: B:L.23, B:A.28, B:I.84, A:A.28, A:I.82, A:I.84 Hydrogen bonds: B:G.27, B:G.27, B:D.29, B:D.30, A:D.29, A:D.30, A:D.30 Salt bridges: B:D.25, A:D.25 Water bridges: A:D.30, A:D.30, A:I.50, A:I.50

17 x IOD: IODIDE ION(Non-functional Binders)

IOD.2: 2 residues within 4Å: Chain A: T.74, N.88 Ligand excluded by PLIP IOD.3: 5 residues within 4Å: Chain A: T.12, K.14, E.65, A.67, G.68 Ligand excluded by PLIP IOD.4: 3 residues within 4Å: Chain A: V.11, T.12, A.67 Ligand excluded by PLIP IOD.5: 4 residues within 4Å: Chain A: K.20, E.21, E.34, N.83 Ligand excluded by PLIP IOD.6: 2 residues within 4Å: Chain A: V.47, G.48 Ligand excluded by PLIP IOD.7: 2 residues within 4Å: Chain A: E.61 Ligands: IOD.8 Ligand excluded by PLIP IOD.8: 1 residues within 4Å: Ligands: IOD.7 Ligand excluded by PLIP IOD.9: 3 residues within 4Å: Chain A: Q.18, M.36, S.37 Ligand excluded by PLIP IOD.11: 1 residues within 4Å: Chain B: K.55 Ligand excluded by PLIP IOD.12: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP IOD.13: 2 residues within 4Å: Chain B: P.39, I.63 Ligand excluded by PLIP IOD.14: 2 residues within 4Å: Chain B: A.67 Ligands: IOD.15 Ligand excluded by PLIP IOD.15: 3 residues within 4Å: Chain B: V.11, T.12 Ligands: IOD.14 Ligand excluded by PLIP IOD.16: 2 residues within 4Å: Chain B: P.39, G.40 Ligand excluded by PLIP IOD.17: 3 residues within 4Å: Chain B: G.73, T.74, N.88 Ligand excluded by PLIP IOD.18: 1 residues within 4Å: Chain B: M.46 Ligand excluded by PLIP IOD.19: 3 residues within 4Å: Chain B: T.12, E.65, G.68 Ligand excluded by PLIP

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.10: 6 residues within 4Å: Chain A: P.39, G.40, R.41, Y.59, D.60, E.61 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.41, A:D.60 GOL.20: 3 residues within 4Å: Chain A: G.51 Chain B: I.54, P.79 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:G.51

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tie, Y. et al., Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors. Protein Sci. (2012)

Release Date

2012-03-21

Peptides

Protease: A
Protease: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Protease

Protease

Related Entries With Identical Sequence